Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

They say not to judge a book by its cover, but how about by its screen adaptation? A film version used to be the logical and desirable next step for any successful literary property, but in the past ...

For the quickest way to join, simply enter your email below and get access. We will send a confirmation and sign you up to our newsletter to keep you updated on all your gaming news.